APA

Lau C. K., Black W. C., Belley M., Chan C., Charleson S., Denis D., Gauthier J. Y., Gordon R., Guay D., Hamel P., Kargman S., Leblanc Y., Mancini J., Ouellet M., Percival D., Prasit P., Roy P., Skorey K., Tagari P., Vickers P. & Wong E. (19971230). From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. : Advances in experimental medicine and biology.

Chicago

Lau C K, Black W C, Belley M, Chan C, Charleson S, Denis D, Gauthier J Y, Gordon R, Guay D, Hamel P, Kargman S, Leblanc Y, Mancini J, Ouellet M, Percival D, Prasit P, Roy P, Skorey K, Tagari P, Vickers P and Wong E. 19971230. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. : Advances in experimental medicine and biology.

Harvard

Lau C. K., Black W. C., Belley M., Chan C., Charleson S., Denis D., Gauthier J. Y., Gordon R., Guay D., Hamel P., Kargman S., Leblanc Y., Mancini J., Ouellet M., Percival D., Prasit P., Roy P., Skorey K., Tagari P., Vickers P. and Wong E. (19971230). From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. : Advances in experimental medicine and biology.

MLA

Lau C K, Black W C, Belley M, Chan C, Charleson S, Denis D, Gauthier J Y, Gordon R, Guay D, Hamel P, Kargman S, Leblanc Y, Mancini J, Ouellet M, Percival D, Prasit P, Roy P, Skorey K, Tagari P, Vickers P and Wong E. From indomethacin to a selective COX-2 inhibitor. Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. : Advances in experimental medicine and biology. 19971230.